# Arvin Yang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/arvin-yang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,616 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 14 |
| i10-index | 16 |
| Last Known Institution | Swim Across America |
| OpenAlex ID | https://openalex.org/A5102145619 |
| Works | 32 |

## Researcher papers

- [Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-melanoma-who-progressed/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

## Researcher university

- [Swim Across America](https://scholariq.org/institutions/swim-across-america/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.